Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FB9HN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,979
Award facts
- Contract value 100% obligated
- $19,979.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,979.31 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (quantity: 60 units) on November 24, 2025, with a completion date of November 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical supplier to federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical contract, the company fulfills diverse pharmaceutical requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. Otezla (apremilast) is a systemic immunosuppressive medication commonly prescribed for dermatological and rheumatological conditions and is consistent with AmerisourceBergen's demonstrated capability to supply specialized pharmaceutical products through the federal supply chain.
Quick answers
Who was awarded contract SPE2DR26FB9HN?
SPE2DR26FB9HN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FB9HN worth?
The government has obligated $19,979 on SPE2DR26FB9HN.
Is contract SPE2DR26FB9HN an order under another contract?
Yes. SPE2DR26FB9HN is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9HN competed?
The extent of competition for SPE2DR26FB9HN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award